Tuesday, Jun 25, 2019
engineered enzymes for better healthcare

Enzolve Technologies is led by an expert management team which includes top scientists and leading business professionals.

Prof. Paul Engel (Chairman)

Dr Suren Aghajanian (Chief Executive Officer)

Dr Jim Walsh (non-Executive Director)

Prof. Stephen Mayhew (Consultant)

Ms. Marie Rooney (Consultant)


Language Selection


Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…


Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…


UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…